In the past decade, many centers have switched to radial access (RA) to perform cardiac catheterization on the grounds that it would reduce local vascular access site complications (VASC) and favor fast track patient management. However, its use remains highly variable. The study by Azzalini et al. (1) raises an unforeseen drawback of RA, which is a paradoxical increase in VASC risk with the femoral access (FA) when it is still used; this questions the net benefit of the RA over the classic FA approach. In their carefully designed study, they addressed several potential confounders of the FA paradox such as the severity of illness of the patients in whom the FA has been used, the progressive loss of skills when the physician changes from the FA to the RA, and new anticoagulant therapies. Yet, 1 crucial point is omitted in estimating the real benefit of switching to the RA in the cath lab, which is the rate of RA use. In their report, their contemporary cohort encompasses a rate of RA of only 46%, which is much lower than the rate of a center accustomed to using, by default, the RA (2). Based on the VASC risk reported by Azzalini et al. (1) In a way, the simplest and almost trivial message of the paper by Azzalini et al. (1), rather than questioning its advantage, is to favor the RA in most cases, which is currently largely feasible. There are several important lessons to be learned from this ongoing discussion. First is that causation cannot be assumed from observational data, not even when used in the context of an attributable fraction.
Second is the importance of backing up opinions with objective data, not expertise alone. Third, and perhaps most important, is to diligently consider safety signals and explore how these signals can be addressed to improve the quality of care.
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